ZA964764B - (R)-(Z)-1-Azabicyclo ¬2.2.1¾ heptan-3-one 0-¬3-(3-methoxy-phenyl)-2-propynyl¾ oxime maleate as a pharmaceutical agent - Google Patents

(R)-(Z)-1-Azabicyclo ¬2.2.1¾ heptan-3-one 0-¬3-(3-methoxy-phenyl)-2-propynyl¾ oxime maleate as a pharmaceutical agent

Info

Publication number
ZA964764B
ZA964764B ZA964764A ZA964764A ZA964764B ZA 964764 B ZA964764 B ZA 964764B ZA 964764 A ZA964764 A ZA 964764A ZA 964764 A ZA964764 A ZA 964764A ZA 964764 B ZA964764 B ZA 964764B
Authority
ZA
South Africa
Prior art keywords
heptan
azabicyclo
methoxy
phenyl
pharmaceutical agent
Prior art date
Application number
ZA964764A
Other languages
English (en)
Inventor
Howard Yoshihisa Ando
Stephen Douglas Barrett
Juan Carlos Jaen
Steven Edward Rose
Haile Tecle
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of ZA964764B publication Critical patent/ZA964764B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
ZA964764A 1995-06-07 1996-06-06 (R)-(Z)-1-Azabicyclo ¬2.2.1¾ heptan-3-one 0-¬3-(3-methoxy-phenyl)-2-propynyl¾ oxime maleate as a pharmaceutical agent ZA964764B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/474,622 US5534522A (en) 1995-06-07 1995-06-07 (R)-(Z)-1-azabicyclo [2.2.1] heptan-3-one,O-[3-(3-methoxyphenyl)-2-propynyl] oxime maleate as a pharmaceutical agent

Publications (1)

Publication Number Publication Date
ZA964764B true ZA964764B (en) 1997-01-08

Family

ID=23884337

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA964764A ZA964764B (en) 1995-06-07 1996-06-06 (R)-(Z)-1-Azabicyclo ¬2.2.1¾ heptan-3-one 0-¬3-(3-methoxy-phenyl)-2-propynyl¾ oxime maleate as a pharmaceutical agent

Country Status (25)

Country Link
US (1) US5534522A (xx)
EP (1) EP0839148B1 (xx)
JP (1) JPH11506723A (xx)
KR (1) KR100383031B1 (xx)
CN (1) CN1063181C (xx)
AT (1) ATE187967T1 (xx)
BG (1) BG63571B1 (xx)
CA (1) CA2219753A1 (xx)
CZ (1) CZ286528B6 (xx)
DE (1) DE69605800T2 (xx)
DK (1) DK0839148T3 (xx)
EA (1) EA000381B1 (xx)
EE (1) EE03971B1 (xx)
ES (1) ES2142586T3 (xx)
GE (1) GEP19991874B (xx)
GR (1) GR3032772T3 (xx)
HK (1) HK1018055A1 (xx)
HU (1) HUP9802499A3 (xx)
NO (1) NO308901B1 (xx)
NZ (1) NZ307946A (xx)
PL (1) PL323796A1 (xx)
SK (1) SK282824B6 (xx)
UA (1) UA46032C2 (xx)
WO (1) WO1996040687A1 (xx)
ZA (1) ZA964764B (xx)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9601909A (pt) * 1995-07-13 1999-10-13 Smithkline Beecham Corp N,n-dietil-8,8-dipropil-2-azaspiro(4,5)decano-2-propan amina dimaleato
US6528529B1 (en) 1998-03-31 2003-03-04 Acadia Pharmaceuticals Inc. Compounds with activity on muscarinic receptors
US7544681B2 (en) 2001-09-27 2009-06-09 Ramot At Tel Aviv University Ltd. Conjugated psychotropic drugs and uses thereof
JP4933259B2 (ja) * 2003-10-02 2012-05-16 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー ピロール置換インドリノン化合物の塩および多形
US7741358B2 (en) * 2005-04-14 2010-06-22 N.V. Organon Crystal form of asenapine maleate
MX2007015511A (es) * 2005-06-07 2008-03-06 Univ Ramot Sales novedosas de farmacos sicotropicos conjugados y procesos para prepararlas.
EP2275095A3 (en) 2005-08-26 2011-08-17 Braincells, Inc. Neurogenesis by muscarinic receptor modulation
EP2258358A3 (en) 2005-08-26 2011-09-07 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
JP2009512711A (ja) 2005-10-21 2009-03-26 ブレインセルス,インコーポレイティド Pde阻害による神経新生の調節
CA2625210A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
WO2007134136A2 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
AU2007249435A1 (en) 2006-05-09 2007-11-22 Braincells, Inc. 5 HT receptor mediated neurogenesis
EP2051735B1 (en) 2006-07-17 2012-08-29 Ramot, at Tel Aviv University Ltd. Conjugates comprising a psychotropic drug or a gaba agonist and an organic acid and their use treating pain and other cns disorders
KR20090064418A (ko) 2006-09-08 2009-06-18 브레인셀즈 인코퍼레이션 4-아실아미노피리딘 유도체 포함 조합물
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
WO2009101616A1 (en) 2008-02-11 2009-08-20 Ramot At Tel Aviv University Ltd. Novel conjugates for treating neurodegenerative diseases and disorders
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
AU2010329440A1 (en) 2009-12-09 2012-08-09 Bar-Ilan University Methods of improving cognitive functions
AU2011219529A1 (en) 2010-02-24 2012-08-30 Bar-Ilan University Crystalline forms of the tri-mesylate salt of perphenazine-GABA and process of producing the same
WO2012038963A1 (en) 2010-09-22 2012-03-29 Ramot At Tel-Aviv University Ltd. An acid addition salt of a nortriptyline-gaba conjugate and a process of preparing same
JP5997931B2 (ja) * 2011-05-25 2016-09-28 石原産業株式会社 農園芸用殺菌剤組成物及び植物病害の防除方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5306718A (en) * 1990-03-06 1994-04-26 Warner-Lambert Company Oxime and amine substituted azabicyclo and azocyclo muscarinic agonists and methods of treatment
US5346911A (en) * 1990-03-06 1994-09-13 Warner-Lambert Company Azabicyclo and azacyclo oxime and amine cholinergic agents and methods of treatment

Also Published As

Publication number Publication date
EP0839148A1 (en) 1998-05-06
US5534522A (en) 1996-07-09
EA000381B1 (ru) 1999-06-24
DK0839148T3 (da) 2000-05-22
NO975704D0 (no) 1997-12-05
PL323796A1 (en) 1998-04-27
NO975704L (no) 1998-01-30
BG102078A (en) 1998-11-30
UA46032C2 (uk) 2002-05-15
AU5744996A (en) 1996-12-30
KR100383031B1 (ko) 2003-10-17
WO1996040687A1 (en) 1996-12-19
CZ286528B6 (cs) 2000-05-17
NZ307946A (en) 2001-03-30
EP0839148B1 (en) 1999-12-22
SK282824B6 (sk) 2002-12-03
BG63571B1 (bg) 2002-05-31
GR3032772T3 (en) 2000-06-30
HUP9802499A2 (hu) 1999-04-28
JPH11506723A (ja) 1999-06-15
AU697954B2 (en) 1998-10-22
CA2219753A1 (en) 1996-12-19
ATE187967T1 (de) 2000-01-15
CN1063181C (zh) 2001-03-14
EA199800007A1 (ru) 1998-06-25
GEP19991874B (en) 1999-12-06
CN1186493A (zh) 1998-07-01
KR19990022572A (ko) 1999-03-25
SK164497A3 (en) 1998-06-03
ES2142586T3 (es) 2000-04-16
DE69605800D1 (de) 2000-01-27
HK1018055A1 (en) 1999-12-10
EE9700316A (et) 1998-06-15
CZ381797A3 (cs) 1998-05-13
EE03971B1 (et) 2003-02-17
HUP9802499A3 (en) 1999-06-28
DE69605800T2 (de) 2000-11-16
NO308901B1 (no) 2000-11-13

Similar Documents

Publication Publication Date Title
ZA964764B (en) (R)-(Z)-1-Azabicyclo ¬2.2.1¾ heptan-3-one 0-¬3-(3-methoxy-phenyl)-2-propynyl¾ oxime maleate as a pharmaceutical agent
CA2213497A1 (en) Method for manufacturing a mineral wool product
HRP960312B1 (en) NOVEL PROCESS FOR THE PRODUCTION OF AMORPHOUS /R-(R*, R*)/-2-(4-FLUOROPHENYL)-"beta", "delta"-DIHYDROXY-5-PHENYL-4-/(PHENYLAMINO)CARBONYL/-1H-PYRROLE -1-HEPTANOIC ACID CALCIUM SALT (2 : 1)
AU6029590A (en) A process for the preparation of rubber-reinforced monovinylidene aromatic polymers
CA2356300A1 (en) 3-azabicyclo[3.1.0]hexane derivatives useful in therapy
CA2178262A1 (en) Process for the preparation of microcapsule compositions
AU633635B2 (en) Process for preparing bituminous compositions
CA2243542A1 (en) Resolution of threo-methylphenidate
AU2460900A (en) Shortened-chain polynucleotides and process for the preparation thereof
ZA979268B (en) L-tartaric acid salt of a(1r) diastereomer of a 2-azadihy-droxybicyclo [2.2.1]heptane compound and the preparation of 2-azabicyclo[2.2.1] heptane compounds
CA2181566A1 (en) Compositions and Methods Using Unbound MPL Receptor for Stimulating Platelet Production
CA2219308A1 (en) New process for the preparation of ropivacaine hydrochloride monohydrate
MX9708337A (es) Maleato (r)-(z)-1-azabiciclo [2.2.1]heptan-3-one,0-[3-(3-metoxifenil)-2-propinil]-oxime como un agente farmaceutico.
CA2281471A1 (en) Process for preparing eprosartan
CA2281708A1 (en) Process for preparing eprosartan
NO175565C (no) Fremgangsmåte for fremstilling av et parenteralt anvendbart, farmasöytisk preparat inneholdende et bis-indolalkaloid
EP0374410A3 (en) 2-Azabicyclo[2.2.1]hept-5-ene-2-acetic acid, derivatives thereof and related compounds, process for the preparation of said compounds and the use of said compounds for the manufacture of N-phosphonomethylglycine
HUP0201301A2 (en) Polymorphs of a crystalline azabicyclo(2,2,2)octan-3-amine citrate and their pharmaceutical compositions and process for preparation of the compounds
CA2227194A1 (en) Resolution of 1-azabicyclo[2.2.2]octan-3-amine, 2-(diphenylmethyl)-n-[[2-methoxy-5-(1-methylethyl)phenyl]methyl]
AU9198698A (en) Process for the preparation of substituted 5,6-dihydro-2h-pyran-2-ones
AU6067098A (en) Preparation process for 3,4-disubstituted dinitroanilines
CA2031578A1 (en) Process for the preparation of molluscicidal 2,4,5-tribromopyrrole-3-carbonitrile compounds
SI0839148T1 (en) (r)-(z)-1-azabicyclo 2.2.1)heptan-3-one,o- 3-(3-methoxyphenyl)-2-propynyl)oxime maleate as a pharmaceutical agent
WO2000063175A3 (en) Novel process
HUP9801822A3 (en) New bis-pyrido[4,3-b]carbozole compounds, a process for their preparation and pharmaceutical compositions containing them